Compare NNNN & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | ODC |
|---|---|---|
| Founded | 2021 | 1941 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 790.1M |
| IPO Year | 2025 | N/A |
| Metric | NNNN | ODC |
|---|---|---|
| Price | $28.31 | $51.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 26.7K | ★ 72.9K |
| Earning Date | 04-28-2026 | 12-08-2025 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | N/A | ★ 17.33 |
| EPS | 0.06 | ★ 3.63 |
| Revenue | $8,185,146.00 | ★ $478,113,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $536.79 | ★ $13.77 |
| Revenue Growth | ★ 21.95 | 5.29 |
| 52 Week Low | $5.18 | $40.66 |
| 52 Week High | $55.65 | $69.76 |
| Indicator | NNNN | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 50.86 | 41.15 |
| Support Level | $26.89 | $45.61 |
| Resistance Level | $44.73 | $55.88 |
| Average True Range (ATR) | 5.91 | 2.29 |
| MACD | 0.18 | -0.38 |
| Stochastic Oscillator | 38.01 | 48.25 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.